A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2006
10/25/2006	CN1281241C Medicine for treating chronic bronchitis and its preparation method
10/25/2006	CN1281240C Medicinal composition for preventing and treating cardiovascular heart disease and its preparation
10/25/2006	CN1281239C Chinese medicine composition for treating stone
10/25/2006	CN1281238C External-applied medicine for treating terminal neuritis and preparation thereof
10/25/2006	CN1281237C Radiation-proof frost-like powder for beauty white and dispelling speckle
10/25/2006	CN1281234C Headache treating Chinese medicine
10/25/2006	CN1281233C Orally disintegrating tablet of 'Shuanghuanglian' and its preparation
10/25/2006	CN1281232C Method for preparing compound licorice buccal tablet
10/25/2006	CN1281228C Medicine for hyperplasia of mammary glands and its preparation
10/25/2006	CN1281226C Pain-dispersing emplastrum
10/25/2006	CN1281222C Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
10/25/2006	CN1281221C Composition for treatment and/or improvement functionality dyspepsia and/or wean anorexia disease and preparation method
10/25/2006	CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism
10/25/2006	CN1281214C Process for preparing ginkgo leaf extract powder injection
10/25/2006	CN1281213C Process method for preparing sodium chloride injection of ginkgo leaf extract
10/25/2006	CN1281211C Use of oxazolidinone in producing medication of treatment fof ocular infections of mammal
10/25/2006	CN1281209C Stabilised oversaturated transdermal therapeutical matrix system
10/25/2006	CN1281208C Liuwei Dihuang dripping pill preparation and method for preparing the same
10/25/2006	CN1281207C Globeflower oral disintegration tablet and its preparing method
10/25/2006	CN1281206C Orally disintegrating tablet of 'Xinxuekang' and manufacture method of the same
10/25/2006	CN1281150C Melissa powder honeyed pill and its preparation method
10/24/2006	US7127286 Implantable device using ultra-nanocrystalline diamond
10/24/2006	US7125911 Autonomic nerve regulating agent
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125909 Sterile parenteral nutrition compositions
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125859 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced
10/24/2006	US7125718 Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same
10/24/2006	US7125568 Lipophilic drug compositions
10/24/2006	US7125567 Coating encapsulation a cores
10/24/2006	US7125566 Particulate drug-containing products and method of manufacture
10/24/2006	US7125565 Composition improved in the solubility or oral absorbability
10/24/2006	US7125564 Glycyrrhizin complex
10/24/2006	US7125563 Sustained release pharmaceutical preparations and methods for producing the same
10/24/2006	US7125562 Rapidly disintegrating methylcellulose tablets
10/24/2006	US7125561 Mixture of drug and deactivating compound; separated by (semi)permeable membrane; partitions become impervious upon activation
10/24/2006	US7125560 Pharmaceutical composition of topiramate
10/24/2006	US7125558 Process for the preparation of activated polyethylene glycols
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006	US7125555 Oral preparation containing seaweed for reduction of plaque and calculus
10/24/2006	US7125546 Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2006	US7125453 High temperature high pressure capsule for processing materials in supercritical fluids
10/24/2006	CA2336004C Use of histamine h2 agonists for the treatment of multiple sclerosis
10/24/2006	CA2330904C Fosinopril sodium tablet formulation
10/24/2006	CA2278541C Pharmaceutical preparations and methods for their regional administration
10/24/2006	CA2276587C Silicone core long term androgen delivery implant
10/24/2006	CA2275587C Injectable depot gel composition and method of preparing the composition
10/24/2006	CA2263361C Implant for subcutaneous or intradermal injection
10/24/2006	CA2257121C Methods and compositions for treating urinary incontinence using optically pure (s)-oxybutynin
10/24/2006	CA2253811C Taste masked liquid suspensions
10/24/2006	CA2252717C Colchicine-skeleton compounds, their use as medicaments and compositions containing them
10/24/2006	CA2252600C Secondary shaping of ionically cross-linked polymer compositions for medical devices
10/24/2006	CA2212744C Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
10/24/2006	CA2207098C Banded prolonged release active agent dosage form
10/24/2006	CA2168877C Agent for curing neuronal diseases
10/24/2006	CA2073561C Polyanhydrides of the oligomerized unsaturated aliphatic acids
10/19/2006	WO2006110815A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
10/19/2006	WO2006110811A1 Nanoparticulate quinazoline derivative formulations
10/19/2006	WO2006110809A2 Nanoparticulate lipase inhibitor formulations
10/19/2006	WO2006110807A1 Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
10/19/2006	WO2006110802A1 Nanoparticulate and controlled release compositions comprising cyclosporine
10/19/2006	WO2006110800A1 Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
10/19/2006	WO2006110487A1 Sustained release implants for subretinal delivery
10/19/2006	WO2006110366A1 Medical devices and methods for producing the same
10/19/2006	WO2006109737A1 Pranlukast hydrate-containing preparation having relieved bitterness
10/19/2006	WO2006109734A1 External agent for treating wound
10/19/2006	WO2006109675A1 Antitumor agent and novel dnase
10/19/2006	WO2006109635A1 Intestinal absorptive anti-tumor agent
10/19/2006	WO2006109325A1 Band-aid with a disinfectant container
10/19/2006	WO2006109317A1 A process for the preparation of poly dl-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein
10/19/2006	WO2006109183A1 Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
10/19/2006	WO2006109177A1 Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles
10/19/2006	WO2006109175A2 Solid dosage form of an antidiabetic drug
10/19/2006	WO2006109104A1 New type of phase separation of micellar colloid solutions
10/19/2006	WO2006109053A2 Controlled release devices and structural elements for use in their manufacture
10/19/2006	WO2006108933A1 Rechargeable dermal patch
10/19/2006	WO2006108692A2 Dosage form for oral administration of a vitamin
10/19/2006	WO2006108643A2 Organic compounds
10/19/2006	WO2006108637A2 Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof
10/19/2006	WO2006108519A1 Therapeutic combination in case of benign prostate hyperplasia
10/19/2006	WO2006108324A1 A gynecological pharmaceutics-containing microspherical vascular suppository of sodium alginate and its preparation method
10/19/2006	WO2006108239A1 Ocular drug delivery
10/19/2006	WO2006089312A3 Orally bioavailable cci-779 tablet formulations
10/19/2006	WO2006085208A3 Stable solid dosage forms of amlodipine and benazepril
10/19/2006	WO2006084139A3 An implantable interferon-containing device
10/19/2006	WO2006083979A3 Local treatment of neurofibromas
10/19/2006	WO2006082398A3 Nucleic acid constructs
10/19/2006	WO2006079722A3 Compositions for freeze-drying proteins
10/19/2006	WO2006079409A3 Spray dried compositions
10/19/2006	WO2006078699A3 Oral care compositions derived from the labiatae family
10/19/2006	WO2006078320A3 Methods for manufacturing delivery devices and devices thereof
10/19/2006	WO2006074218A3 Nanoparticulate candesartan formulations
10/19/2006	WO2006069719A3 Lyophilization of virosomes
10/19/2006	WO2006065951A3 Sustained delivery formulations of octreotide compounds
10/19/2006	WO2006063350A3 Compositions and methods for treating conditions of the nail unit
10/19/2006	WO2006060618A3 Topical nepafenac formulations
10/19/2006	WO2006050303A3 Intravaginal treatment of vaginal infections with metronidazole compositions
10/19/2006	WO2006048772A3 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof

1 ... 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 ... 2991